Page last updated: 2024-08-21

erythromycin and sildenafil citrate

erythromycin has been researched along with sildenafil citrate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Butrous, G; Siegel, RL1
Faulkner, S; Harness, JA; Muirhead, GJ; Taubel, J1

Trials

1 trial(s) available for erythromycin and sildenafil citrate

ArticleYear
The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.
    British journal of clinical pharmacology, 2002, Volume: 53 Suppl 1

    Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Biological Availability; Drug Combinations; Erythromycin; Half-Life; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyrimidinones; Sildenafil Citrate; Sulfones

2002

Other Studies

2 other study(ies) available for erythromycin and sildenafil citrate

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current.
    Circulation, 2001, Jun-12, Volume: 103, Issue:23

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Animals; Biological Availability; Cation Transport Proteins; Cells, Cultured; Cricetinae; Cyclic Nucleotide Phosphodiesterases, Type 5; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Erectile Dysfunction; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Heart; Heart Conduction System; Humans; Male; Mixed Function Oxygenases; Myocardium; Piperazines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Purines; Sildenafil Citrate; Sulfones; Trans-Activators; Transcriptional Regulator ERG

2001